Study shows Tri-Low extract of amla’s efficacy in reducing dyslipidemia
date:Mar 26, 2019
ial, major lipids including total cholesterol, triglycerides, LDL cholesterol and VLDL were significantly lower in the amla group compared to the placebo group.

At the same time, anti-atherogenic lipoproteins, such as HDL-cholesterol, were maintained at optimum levels. A 39 per cent reduction in atherogenic index of the plasma (AIP) a key indicator of cardiac health also was noted in the amla group.

Lipid balance was achieved with no concomitant reduction of plasma CoQ10 levels, a phenomenon
3/8 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/03 09:02